Parfrey P S, Harnett J D, Griffiths S, Gault M H, Barre P E, Guttmann R D
Am J Nephrol. 1987;7(3):184-91. doi: 10.1159/000167461.
To determine the factors associated with low-output left ventricular failure (LVF) in endstage renal disease (ESRD), we performed echocardiography and gated cardiac scan on 217 nondiabetic dialysis and transplant patients. The prevalence of low-output LVF (ejection fraction less than 55% and left ventricular end diastolic diameter greater than or equal to 5.5 cm) in dialysis patients was 18% and in transplant patients 2%. The 26 patients with LVF were compared to 52 controls without LVF, matched by age, sex and year of starting treatment for ESRD, but not for current ESRD therapy. Mean age was 55 +/- (SEM) 14 years; 73% of the patients in both groups were males. Duration of treatment for ESRD was 5.6 +/- 4.3 years in patients, compared to 5.1 +/- 4.1 years in controls. Significant differences between LVF patients and controls included current treatment (73% of cases were on hemodialysis and 8% were transplanted, compared to 48 and 42%; chi 2 = 9.9, p less than 0.01), high serum creatinine, smoking and high serum alkaline phosphatase. There were no differences for current blood pressure, proportion on treatment for hypertension, left ventricular wall thickness, symptomatic ischemic heart disease, proportion with functioning vascular access, degree of weight gain between dialyses, hemoglobin level or high transfusion requirement. Multiple logistic regression demonstrated the most significant and independent variables associated with LVF were high alkaline phosphatase (suggestive of hyperparathyroidism), smoking and high serum creatinine levels (reflecting degree of uremia). Dialysis patients with LVF (n = 23) were compared to dialysis patients who had normal echocardiograms (n = 29).(ABSTRACT TRUNCATED AT 250 WORDS)
为了确定终末期肾病(ESRD)患者低输出量左心室衰竭(LVF)的相关因素,我们对217例非糖尿病透析及移植患者进行了超声心动图检查和门控心脏扫描。透析患者中低输出量LVF(射血分数小于55%且左心室舒张末期直径大于或等于5.5 cm)的患病率为18%,移植患者中为2%。将26例LVF患者与52例无LVF的对照者进行比较,两组在年龄、性别及开始治疗ESRD的年份上匹配,但当前的ESRD治疗情况不匹配。平均年龄为55±(标准误)14岁;两组中73%的患者为男性。ESRD患者的治疗时长为5.6±4.3年,对照者为5.1±4.1年。LVF患者与对照者之间的显著差异包括当前治疗方式(73%的病例接受血液透析,8%接受移植,而对照者分别为48%和42%;χ² = 9.9,p<0.01)、高血清肌酐、吸烟及高血清碱性磷酸酶。在当前血压、高血压治疗比例、左心室壁厚度、有症状的缺血性心脏病、有功能的血管通路比例、透析间期体重增加程度、血红蛋白水平或高输血需求方面无差异。多因素logistic回归显示,与LVF相关的最显著且独立的变量是高碱性磷酸酶(提示甲状旁腺功能亢进)、吸烟及高血清肌酐水平(反映尿毒症程度)。将LVF的透析患者(n = 23)与超声心动图正常的透析患者(n = 29)进行比较。(摘要截短至250词)